Back
SELLAS Life Sciences Group Vs. Dave Industry Stock Comparison
Sell
29
SLS
SELLAS Life Sciences Group
Last Price:
$1.06
Seasonality Move:
9.08%
Buy
79
DAVE
Dave
Last Price:
$89.93
Seasonality Move:
87.09%
Sell
29
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
-
The current SELLAS Life Sciences Group [SLS] share price is $1.08. The Score for SLS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
SLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.08The current trend is relatively stagnant and SLS is experiencing slight buying pressure.
DAVE Stock Price Chart
SLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 55.58 | Buy |
Chaikin Money Flow: | 159232 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.9 - 1.12) | Buy |
Bollinger Bands (100): | (1.06 - 1.3) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.46 | Buy |
Relative Strength Index (14 RSI): | 52.27 | Buy |
Chaikin Money Flow: | 230735 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86 - 96.94) | Sell |
Bollinger Bands (100): | (33.53 - 81.33) | Buy |
SLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1 | Buy |
20-day SMA: | 0.97 | Buy |
50-day SMA: | 1.11 | Sell |
200-day SMA: | 1.23 | Sell |
8-day EMA: | 1.02 | Buy |
20-day EMA: | 1.01 | Buy |
50-day EMA: | 1.08 | Sell |
200-day EMA: | 1.2 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.67 | Sell |
20-day SMA: | 91.33 | Sell |
50-day SMA: | 75.49 | Buy |
200-day SMA: | 48.04 | Buy |
8-day EMA: | 91.08 | Sell |
20-day EMA: | 89.83 | Buy |
50-day EMA: | 78.42 | Buy |
200-day EMA: | 51.17 | Buy |
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.02 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $1.12 per share.
SELLAS Life Sciences Group Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |